Analyst Price Target is $2.70
▲ +344.74% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for IceCure Medical in the last 3 months. The average price target is $2.70, with a high forecast of $2.90 and a low forecast of $2.50. The average price target represents a 344.74% upside from the last price of $0.61.
Current Consensus is
Buy
The current consensus among 2 polled investment analysts is to buy stock in IceCure Medical. This Buy consensus rating has held steady for over two years.
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Read More